An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public trust.
A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
In a new study, bats lap up vaccine-laced saline or chow down on vaccine-carrying mosquitoes. Will that have any impact on the flying mammal's immune system?
In 2020, President Donald Trump declared a national emergency in response to the COVID-19 pandemic. On this date, the novel coronavirus had killed three dozen people in the United States and sickened ...
Earlier this month in Washington, D.C., a U.S. Congressional panel held an independent hearing with several medical specialists to examine the record number of injuries, disabilities, and deaths ...
KEYTRUDA QLEX is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute “This approval is significant for ...
A new study led by the Centenary Institute and the University of Sydney shows that a nasal vaccine could offer powerful protection against COVID-19. It works by stopping infection in the nose before ...
The Food and Drug Administration approved the next round of COVID-19 vaccines Wednesday, but imposed new restrictions on who's eligible to get receive them. The agency is limiting the updated shots to ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results